General Information of the Compound
| Compound ID |
CP0535188
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-[(1R)-2-oxo-1-phenyl-2-[(2S)-2-[5-[4-[4-[2-[(2S)-1-[(2S)-2-phenyl-2-(pyridine-3-carbonylamino)acetyl]pyrrolidin-2-yl]-1,3-thiazol-5-yl]phenyl]phenyl]-1,3-thiazol-2-yl]pyrrolidin-1-yl]ethyl]pyridine-3-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C54H46N8O4S2
|
||||||||||||||||||
| Molecular Weight |
935.148
|
||||||||||||||||||
| Canonical SMILES |
O=C(N[C@@H](C(=O)N1CCC[C@H]1c1ncc(s1)-c1ccc(cc1)-c1ccc(cc1)-c1cnc(s1)[C@@H]1CCCN1C(=O)[C@@H](NC(=O)c1cccnc1)c1ccccc1)c1ccccc1)c1cccnc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C54H46N8O4S2/c63-49(41-15-7-27-55-31-41)59-47(39-11-3-1-4-12-39)53(65)61-29-9-17-43(61)51-57-33-45(67-51)37-23-19-35(20-24-37)36-21-25-38(26-22-36)46-34-58-52(68-46)44-18-10-30-62(44)54(66)48(40-13-5-2-6-14-40)60-50(64)42-16-8-28-56-32-42/h1-8,11-16,19-28,31-34,43-44,47-48H,9-10,17-18,29-30H2,(H,59,63)(H,60,64)/t43-,44-,47-,48+/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
FVCQAYIVXIVRSR-ONFDFNSZSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound